Atlas Trials

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Clinical trial NCT01485601 · COMPLETED

Trial details

NCT number
NCT01485601
Sponsor
Medy-Tox
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Glabellar Frown Lines
Start date
2011-12-07
Primary completion
2012-03-30
Enrollment
121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.